Bill

Bill > SB417


MT SB417

MT SB417
Generally revise laws relating to insurance coverage relating to obesity prevention


summary

Introduced
02/21/2025
In Committee
02/24/2025
Crossed Over
Passed
Dead
05/23/2025

Introduced Session

2025 Regular Session

Bill Summary

AN ACT ENTITLED: “AN ACT REVISING HEALTH INSURANCE LAW TO REQUIRE COVERAGE OF CERTAIN INJECTABLE MEDICINES TO IMPROVE GLUCOSE OR WEIGHT LOSS; PROVIDING REQUIREMENTS FOR COVERAGE; PROVIDING EXCEPTIONS; AND AMING SECTIONS 2-18-704, 33- 31-111, AND 33-35-306, MCA.”

AI Summary

This bill requires health insurance policies in Montana to provide coverage for injectable medicines prescribed to improve glucose levels or promote weight loss for adults diagnosed with prediabetes, gestational diabetes, or obesity. The coverage must be considered medically necessary and determined by a licensed physician, and can be prescribed either on-label or off-label. To continue receiving coverage, patients must participate in a lifestyle management plan administered by their health plan if given advance written notice. The bill specifically excludes individuals covered by Medicare Advantage prescription drug plans from these requirements. The legislation amends several existing state insurance laws to incorporate this new coverage mandate, ensuring that individual policies, group plans, health maintenance organizations, and self-funded multiple employer welfare arrangements must adhere to these new requirements. By mandating this coverage, the bill aims to improve access to medical treatments that can help manage and potentially prevent chronic health conditions related to glucose metabolism and weight.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

(S) Died in Process (on 05/23/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...